Health-care systems and pharmacoeconomic research in Asia-Pacific region

Value in Health

Volumn 11, Issue SUPPL. 1, 2008, Pages

  Tarn, Yen Huei ^a,j   Hu, Shanlian ^b   Kamae, Isao ^c   Yang, Bong Min ^d   Li, Shu Chuen ^e   Tangcharoensathien, Viroj ^f   Teerawattananon, Yot ^f   Limwattananon, Supon ^f   Hameed, Aamir ^g   Aljunid, Syed M ^h   Bapna, Jawahar S ⁱ  

^a TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^b FUDAN UNIVERSITY   (China)

^c KEIO UNIVERSITY   (Japan)

^d Seoul National University   (South Korea)

^e NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

^f MINISTRY OF PUBLIC HEALTH   (Thailand)

^g AGA KHAN UNIVERSITY   (Pakistan)

^h UNIVERSITI KEBANGSAAN MALAYSIA   (Malaysia)

ⁱ Institute of Health Management Research   (India)

^j Center for Drug Evaluation   (Taiwan)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ASIA; BUDGET; CHINA; CONFERENCE PAPER; COST EFFECTIVENESS ANALYSIS; COST MINIMIZATION ANALYSIS; COST OF ILLNESS; DRUG COST; HEALTH CARE COST; HEALTH CARE DELIVERY; HEALTH CARE FINANCING; HEALTH CARE POLICY; HEALTH CARE SYSTEM; HUMAN; PACIFIC ISLANDS; PRIORITY JOURNAL; REIMBURSEMENT; SOUTH KOREA;

EID: 41749084653     PISSN: 10983015     EISSN: 15244733     Source Type: Journal    
DOI: 10.1111/j.1524-4733.2008.00378.x     Document Type: Conference Paper

References (43)

1. Department of Rural Health Administration. Statistical Manual of New Type of Rural Cooperative Medical System, 2003-2004 & 2005. Beijing : Chinese Ministry of Health, 2005, 2006.
2. China Health Economic Institute. China National Health Accounts. Beijing : China Health Economic Institute, 2006.
3. Hu SL, Tan A, Yang L. The Guidelines of Pharmacoeconomics Evaluation. Shanghai : Fudan University Press, 2005.
4. Ministry of Health, Labor and Welfare. Health care systems reform (in Japanese). 2005.
5. Ministry of Health, Labor and Welfare. Journal of health and welfare statistics (in Japanese). Health and Welfare Statistic Association 2005.
6. Ministry of Health, Labor and Welfare. Statistics of national medical expenditure (in Japanese). 2004.
7. Nakahara N, Kamei M, Tsutani K Drug and evidence. EBM Journal (in Japanese) 2006 7 : 900 9.
8. Ministry of Health and Welfare, Government of Korea. Annual Statistics. Seoal : Ministry of Health and Welfare, Government of Korea, 2003.
9. OECD Reviews of Health Care Systems - Korea. OECD, 2003.
10. National Health Insurance Corporation (NHIC). Annual Statistical Report, various years.
11. Health Insurance Review Agency (HIRA). Internal Report. January 2005.
12. Doherty J, Kamae I, Lee K, et al. What's next for pharmacoeconomics and outcomes research in Asia? Value Health 2004 7 : 118 32.
13. Li SC. Health Care System and Public Sector Drug Formulary in Singapore. ISPOR CONNECTIONS September/;October 2007.
14. Tangcharoensathien V, Tantivess S, Teerawattananon Y, et al. Universal coverage and its impact on reproductive health services in Thailand. Reprod Health Matters 2002 10 : 59 69.
15. Tisayaticom K, Patcharanarumol W, Tangcharoensathien V, et al. SHA Based Health Accounts in Asia Pacific: Country Study of Thailand National Health Account. Nonthaburi : International Heath Policy Program, Ministry of Public Health, 2005.
16. Teerawattananon Y, Russell S. A difficult balancing act: policy actors' perspectives on using economic evaluation to inform health care coverage decisions under the universal health insurance coverage scheme in Thailand. Value in Health 2008 11 (Suppl 1 S52 60.
17. Wibulpolprasert S (ed.). Thailand Health Profile. 2001-2004. Bangkok : Printing Press, Express Transportation Organization, 2005.
18. National Reports on Socio-Economic Survey of Households. Bangkok : National Statistical Office, 2005.
19. Limwattananon S, Limwattananon C, Pannarunothai S. Rapid penetration of COX2 inhibitors in non-steroidal anti-inflammatory drug market: an implication to hospital cost containment policy. In : Second International Conference on Improving Use of Medicines. Chiang Mai 2004.
20. Limwattananon S, Limwattananon C, Pannarunothai S. Accessibility to inhaled corticosteroids among adults with chronic asthma: an impact of the Universal Health care Coverage Policy. In : Second International Conference on Improving Use of Medicines. Chiang Mai 2004.
21. Teerawattananon Y, Tangcharoensathien V, Tantivess S, et al. Health sector regulation in Thailand: recent progress and the future agenda. Health Policy 2003 63 : 323 38.
22. Office for Development of National List of Essential Medicines. The Selection of the 2004 National List of Essential Medicines: Criteria, Rationale and Evidence. Nonthaburi : Office for development of National List of Essential Medicines, 2005.
23. Teerawattananon Y, Russell S, Mugford M. A systematic review of economic evaluation literature in Thailand: is the data good enough to be used by policy-makers? Pharmacoconomics 2007 25 : 467 79.
24. Federal Bureau of Statistics. Government of Pakistan. Islamabad, Pakistan : Federal Bureau of Statistics, 2006. Available from: http://www.statpak.gov. pk/depts/index.html [Accessed November 2006].
25. Nishtar S. The gateway paper: health systems in Pakistan - a way forward. Pakistan's health policy forum. Heartfile 2006 First Gateway paper, p. 2. Available from http://www.heartfile.org/gateway.htm [Accessed January 2007].
26. Nishtar S, Faruqui AMA, Mattu MA, et al. The National Action Plan for the prevention and control of non-communicable diseases and health promotion in Pakistan - Cardiovascular Diseases. J Pak Med Assoc 2004 54 (Suppl. S14 25.
27. Drug Control Organization, Ministry of Health, Government of Pakistan. 2005. Available from: http://www.dcomoh.gov.pk/ [Accessed December 2006].
28. Government of Pakistan. Foreign Trade Statistics of Pakistan. Islamabad, Pakistan : Ministry of Finance, 2003.
29. The Network for Consumer Protection. Report of the committee of the task force on 'review the Drug Act 1976'. Islamabad, Pakistan : The Network for Consumer Protection, 1998.
30. The Network for Consumer Protection. Fighting Drug Shortage. Islamabad, Pakistan : Drug Bulletin 10 (3 & 4) May/;August 2001.
31. Department of Statistics. Malaysia Year Book of Statistics 2004. Kuala Lumpur : Department of Statistics Malaysia, 2004.
32. The National Medicines Use Survey and The National Medical Device Survey. The Malaysian Medical and Health Directory 2006. Kuala Lumpur : The National Medicines Use Survey and The National Medical Device Survey, 2006.
33. Ministry of Health. Malaysia Annual Report, 2004. Kuala Lumpur : Ministry of Health, 2004.
34. Aljunid S. Options for Health Care Financing. Final Research Report Funded by Intensified Research in Priority Areas Project (IRPA) Code IRPA 06-02-02-0038. 2000.
35. Public banking on proposed medical scheme. 1 April 2006. The Star, 2006.
36. Aljunid S, Cheah M, Nyunt-U S, et al. Cost analysis of private primary care services in three urban centres in Malaysia. Malays J Public Health Med 2000 1 : 8 15.
37. Chin TS. Letters to the Editor. 26 October 2006. The New Straits Times, 2006.
38. Aljunid S. Cost-effective medicine and doctors; editorial. Med J Malaysia 2006 61 : 1 3.
39. Goldstein H. Medical education in India does not address larger social needs for health care. Science and Environment Online. Available from: http://www.downtoearth.org.in/cover.asp?foldername=20060715&filename= news&sid=71&sec_id=9 [Accessed April 25, 2007].
40. Lal PG, Byword Editorial Consultants (eds.). Report of the National Commission on Macroeconomics and Health, National Commission on Macroeconomics and Health, Ministry of Health & Family Welfare, Government of India, New Delhi, August 2005.
41. Confederation of Indian Industry. India Brand Equity Foundation News letter. Available from: http://www.indianhealthcarefederation.org/Healthcare.pdf [Accessed March 31, 2006].
42. Department of Chemicals and Petrochemicals, Government of India. Draft National Pharmaceuticals Policy, 2006. December 28, 2005.
43. Bapna JS, Bhoi NK. Impact of drug policy in improving the access to medicines in Delhi. In : Raghavan KS, Mathur VS, eds. The Catalyst. New Delhi : Pragati Offsets Pvt. Ltd., 2006.